Ensign Peak Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.7M | Sell |
|
|||||
|
2025
Q2 | $19.7M | Hold |
|
|||||
|
2025
Q1 | $25M | Sell |
|
|||||
|
2024
Q4 | $31.6M | Sell |
|
|||||
|
2024
Q3 | $19.3M | Sell |
|
|||||
|
2024
Q2 | $16.2M | Sell |
|
|||||
|
2024
Q1 | $26.5M | Buy |
|
|||||
|
2023
Q4 | $8.87M | Hold |
|
|||||
|
2023
Q3 | $7.78M | Buy |
|
|||||
|
2023
Q2 | $4.38M | Hold |
|
|||||
|
2023
Q1 | $3.05M | Hold |
|
|||||
|
2022
Q4 | $3.55M | Hold |
|
|||||
|
2022
Q3 | $4.15M | Hold |
|
|||||
|
2022
Q2 | $3.54M | Hold |
|
|||||
|
2022
Q1 | $4.08M | Hold |
|
|||||
|
2021
Q4 | $5.46M | Buy |
|
|||||
|
2021
Q3 | $4.31M | Hold |
|
|||||
|
2021
Q2 | $5.8M | Hold |
|
|||||
|
2021
Q1 | $6.45M | Hold |
|
|||||
|
2020
Q4 | $8.27M | Buy |
|